Lifestyle program for triple-negative breast cancer patients
Part of Cancer clinical trials.
This study tests a lifestyle program (diet, exercise, and support) for women with triple-negative breast cancer who are getting chemotherapy plus immunotherapy before surgery. The goal is to see if healthy habits can help during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between the ages of 18 and 75.
- You have been diagnosed with early-stage (non-spreading) triple-negative breast cancer.
- Your treatment plan includes chemotherapy and immunotherapy before surgery.
- You are willing to make lifestyle changes, including a high-fiber diet (not a keto diet) and no probiotics.
- You have a laptop or device with a camera to take part in online group sessions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a structured lifestyle program (diet and exercise) can make standard chemotherapy before surgery work better for triple-negative breast cancer. It looks at how the program affects your body’s response to treatment and your overall health.
This study tests whether an exercise program can help women with triple-negative breast cancer during their chemotherapy treatment. You will be asked to participate in a supervised exercise routine while receiving your standard cancer drugs.
This study looks at how your diet and the natural bacteria in your gut (microbiome) may affect how well chemotherapy and immunotherapy work for early-stage triple-negative breast cancer. By participating, you may help doctors understand if certain gut bacteria can improve treatment outcomes.
This trial tests whether a treatment that targets your gut bacteria (microbiome) can help fight triple-negative breast cancer before surgery. It is for people with newly diagnosed, untreated triple-negative breast cancer that has not spread far.
This study looks at how bacteria in your gut might affect the way your body responds to immunotherapy for triple-negative breast cancer. It focuses on women who are overweight or obese and are about to start treatment with pembrolizumab before surgery.
This trial tests whether adding a special low-calorie diet (called a fasting-mimicking diet) to standard chemotherapy and immunotherapy can help treat triple-negative breast cancer before surgery. It aims to see if this combination makes the treatment work better.
Hear when a new Microbiome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.